Fig. 1 | Signal Transduction and Targeted Therapy

Fig. 1

From: Immunological and metabolic characteristics of the Omicron variants infection

Fig. 1

Immune escape by the BA.1 Omicron variant. a The ELISA assay shows the binding ability of 3A2A12, MM43, MM48 and mouse IgG to SARS-CoV-2 RBD (n = 4). b The neutralizing ability of 3A2A12 for SARS-CoV-2 and BA.1 Omicron pseudoviruses (n = 3), p < 0.001, determined by two-way ANOVA. c Inhibition of Delta and BA.1 Omicron pseudoviruses by convalescent patient sera (n = 10). d Inhibition of Delta (left) and BA.1 Omicron (right) pseudoviruses by COVID-19 convalescent patient sera in vaccinees (n = 6) and non-vaccinated group (n = 4). Data are represented as mean ± SEM, p-value was determined by the Wilcoxon rank sum test, (*p < 0.05, **p < 0.01, ***p < 0.001)

Back to article page